IDegAsp

insulin degludec/insulin aspart · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for IDegAsp, covering 2015-10-22 to 2025-01-17. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM [Phase 2]

See pricing